ATE372375T1 - Für den bradykinin-b1-rezeptor kodierende dna - Google Patents

Für den bradykinin-b1-rezeptor kodierende dna

Info

Publication number
ATE372375T1
ATE372375T1 AT95916317T AT95916317T ATE372375T1 AT E372375 T1 ATE372375 T1 AT E372375T1 AT 95916317 T AT95916317 T AT 95916317T AT 95916317 T AT95916317 T AT 95916317T AT E372375 T1 ATE372375 T1 AT E372375T1
Authority
AT
Austria
Prior art keywords
receptor
bradykinin
recombinant
dna coding
host cells
Prior art date
Application number
AT95916317T
Other languages
English (en)
Inventor
David L Linemeyer
John W Hess
Joseph A Borkowski
Kathleen K Bierilo
John G Menke
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22861167&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE372375(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE372375T1 publication Critical patent/ATE372375T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95916317T 1994-04-15 1995-04-10 Für den bradykinin-b1-rezeptor kodierende dna ATE372375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/229,418 US5712111A (en) 1994-04-15 1994-04-15 DNA encoding bradykinin B1 receptor

Publications (1)

Publication Number Publication Date
ATE372375T1 true ATE372375T1 (de) 2007-09-15

Family

ID=22861167

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916317T ATE372375T1 (de) 1994-04-15 1995-04-10 Für den bradykinin-b1-rezeptor kodierende dna

Country Status (8)

Country Link
US (4) US5712111A (de)
EP (1) EP0757716B1 (de)
JP (1) JP2001506481A (de)
AT (1) ATE372375T1 (de)
CA (1) CA2187740C (de)
DE (1) DE69535590T2 (de)
ES (1) ES2292168T3 (de)
WO (1) WO1995028474A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712111A (en) * 1994-04-15 1998-01-27 Merck & Co., Inc. DNA encoding bradykinin B1 receptor
SE9602822D0 (sv) * 1996-07-19 1996-07-19 Astra Pharma Inc New receptor
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6469150B1 (en) * 2000-05-22 2002-10-22 Pharmacopeia, Inc. Cloning and characterization of genes encoding bradykinin B1 receptor homologues from five mammalian species
US20040199934A1 (en) * 2001-08-20 2004-10-07 Hess John W Transgenic rodents as animal moldels for modulation of b1 bradykinin receptor protein
WO2005037994A2 (en) 2003-10-08 2005-04-28 Merck & Co., Inc. Transgenic rodents selectively expressing human b1 bradykinin receptor protein
MX2007013213A (es) * 2005-04-25 2007-12-12 Amgen Inc Composiciones de liberacion prolongada de peptidos biodegradables que contienen porogenos.
BR112013013674A2 (pt) * 2010-12-03 2016-09-06 Diamedica Inc anticorpo monoclonal de receptor anti-bradicinina b2 (bkb2r)
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
ES2625548T3 (es) 2012-06-04 2017-07-19 DiaMedica Therapeutics Inc. Isoformas de glicosilación de la calicreína-1 tisular humana
WO2018165551A1 (en) 2017-03-09 2018-09-13 Diamedica Inc. Dosage forms of tissue kallikrein 1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712111A (en) * 1994-04-15 1998-01-27 Merck & Co., Inc. DNA encoding bradykinin B1 receptor

Also Published As

Publication number Publication date
DE69535590D1 (de) 2007-10-18
CA2187740C (en) 2010-06-29
US6307027B1 (en) 2001-10-23
US5965367A (en) 1999-10-12
EP0757716B1 (de) 2007-09-05
JP2001506481A (ja) 2001-05-22
US5712111A (en) 1998-01-27
WO1995028474A1 (en) 1995-10-26
EP0757716A4 (de) 1999-07-21
CA2187740A1 (en) 1995-10-26
US20030036633A1 (en) 2003-02-20
DE69535590T2 (de) 2008-05-29
ES2292168T3 (es) 2008-03-01
EP0757716A1 (de) 1997-02-12

Similar Documents

Publication Publication Date Title
ATE282087T1 (de) Modifiziertes enzym mit lipolytischer aktivität
ATE310098T1 (de) Dna kodierend für glutaminsäure-gesteuerte chloridkanäle
ATE372375T1 (de) Für den bradykinin-b1-rezeptor kodierende dna
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
IL193919A0 (en) DcR3 POLYPEPTIDE A TNFR HOMOLOG
AR053931A2 (es) Secuencia de adn que codifica una proteina de a. thaliana que posee actividad de delta -5,7-esterol, delta-7-reductasa, proteina delta-7red
FI972390A0 (fi) Sytokiini nimeltä Lerk-7
DE69531302D1 (de) Zellsystem mit einer spezifischen wechselwirkung von peptid-bindenden paaren
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
ATE233788T1 (de) Interleukin-15-rezeptoren
DE69535696D1 (de) Tripeptidyl-aminopeptidase
ATE358725T1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
IL109090A0 (en) Ptp-s31: a novel protein tyrosine phosphatase
CA2032167A1 (en) Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
FI971896A (fi) BMP-tyyppi II-reseptoria koodaava cDNA
DE60033297D1 (de) Für die humane untereinheit 5-ht3-c des serotoninrezeptors 5-ht3 kodierende dna
ATE384739T1 (de) Für den menschlichen vanilloid-rezeptor vr3 kodierende dns
DE59814002D1 (de) Sekretion von tragergebundenen proteinen in das periplasma und in den extrazellulären raum
FR2697850B1 (fr) Nouveaux polypeptides ayant une activité de récepteur opioïde, acides nucléiques codant pour ces polypeptides et utilisations.
DE60129688D1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
DE60031856D1 (de) Säugeradhäsionprotease
ATE309371T1 (de) Protein mit dnase-aktivität
FR2722209B1 (fr) Recepteur opioide kappa humain, acides nucleiques et utilisations
DE69739525D1 (de) Neuer cxc chemokinrezeptor aus maus
WO2000071741A3 (en) Dna encoding a human subunit of the 5-ht3 serotonin receptor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties